InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
0.00%
)
US TECH 100
17,607.60
(
-0.01%
)
Dow Jones
38,852.27
(
0.00%
)
Brent Oil
82.71
(
-0.92%
)
Bitcoin
63,715.96
(
0.88%
)
Post# of 7536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: ash111 post# 7170

Saturday, 09/01/2018 4:56:00 PM

Saturday, September 01, 2018 4:56:00 PM

Post# of 7536
AYTU a well-written article: "First to inspire, the aggregate sum of the markets targeted by AYTU’s two therapeutics Natesto® and ZolpiMist™ are estimated to be worth a combined $3.6BN ($1.8BN each for TRT and sleep), and the unique advantages of AYTU’s products create a clear opportunity for the company to grab a huge portion of this market opportunity".

Can you Believe market cap is only $8m?

https://www.linkedin.com/pulse/crystal-ball-look-aytu-biosciences-q4-earnings-kenny-feigeles

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up